-
Ono-6818
- indication:Investigated for use/treatment in chronic obstructive pulmonary disease (COPD).
- pharmacologypharmacology:
- mechanism: ONO-6818 inhibits neutrophil elastase activity, reducing interleukin 8 production and the formation of the complement membrane attack complex. Consequently, neutrophil elastase levels are reduced during stimulated extracorporeal circulation.
- toxicity:
- absorprion:
- halflife:
- roouteelimination:
- volumedistribution:
- clearance: